Kristina Wallenius - Concepedia

Author

Kristina Wallenius

Sahlgrenska University Hospital ORCID

Also Known As

K. Wallenius, KRISTINA WALLENIUS, Kristina Wallenius

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Sahlgrenska University Hospital AstraZeneca (Sweden)University of Gothenburg AstraZeneca (United States)University of Cambridge

About

Kristina Wallenius is an author at Sahlgrenska University Hospital specializing in medicine, health sciences, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.9K
2	Health Sciences	9	9	1.9K
3	Cell Biology	4	4	209
4	Biochemistry	2	2	42
5	Applied Physiology	1	1	141

Kristina Wallenius

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-6-deficient mice develop mature-onset obesity Ville Wallenius, Kristina Wallenius, Bo Åhrén, Nature Medicine ObesityMetabolic SyndromeInflammationCytokinePhysiology	2002	1.2K
Intracerebroventricular interleukin-6 treatment decreases body fat in rats Kristina Wallenius, Ville Wallenius, David Sunter, Biochemical and Biophysical Research Communications ObesityMetabolic SyndromeInflammationBody CompositionMedicine	2002	237
Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects Kaj Stenlöf, Ingrid Wernstedt Asterholm, Ted Fjällman, The Journal of Clinical Endocrinology & Metabolism	2003	147
Reduced Exercise Endurance in Interleukin-6-Deficient Mice Jenny Fäldt, Ingrid Wernstedt Asterholm, Sharyn M. Fitzgerald, Endocrinology ImmunologyYoung Il-6Il-6 DeficiencyInflammationMetabolic Syndrome	2004	141
Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism Klara Sjögren, Kristina Wallenius, Jun‐Li Liu, Diabetes	2001	138
Effects of Liver-Derived Insulin-Like Growth Factor I on Bone Metabolism in Mice Klara Sjögren, Matilda H.‐C. Sheng, Sofia Movérare, Journal of Bone and Mineral Research	2002	97
Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice Kristina Wallenius, Klara Sjögren, Xiao-ding Peng, Endocrinology Human GrowthPituitary GlandHypothalamic PeptidePituitary GhrfPituitary Disease	2001	82
Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis Cong Liu, Milena Schönke, Enchen Zhou, Cardiovascular Research	2021	69
The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis Kristina Wallenius, Tobias Kroon, Therese Hagstedt, Journal of Lipid Research	2022	63
Involvement of the metabolic sensor GPR81 in cardiovascular control Kristina Wallenius, Pia Thalén, Jan‐Arne Björkman, JCI Insight HypertensionMetabolic RemodelingGpr81 AgonismInsulin SignalingMetabolic Syndrome	2017	57

Page 1